Advertisement

TNDM

Tandem Diabetes Care, Inc.

Healthcare · USD

Set alert

Price alert · TNDM

All alert types
19.11 USD -0.68 -3.44%
As of Oct 30, 2026 Extended hours 19.11 0.00%
Bid
19.09 × 2
Ask
19.12 × 2
18.71 Day range 19.59
12.82 52-week range 28.26
YTD
-13.06%
1 year
+30.98%
Open
19.42
Prev close
19.79
Mkt cap
1.33B
Vol
1.87M
Avg vol
2.13M
EPS
-0.91
P/E
0.00
Div yield
0.00%
More statistics
Low
18.71
High
19.59
Forward P/E
120.22
Beta
1.66
Short ratio
6.27
Inst. own
115.75%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
18.09
200-d avg
18.94
1y target
27.76

2Y chart

Chart tools
Interval
TNDM two-year price chart9.9817.124.131.238.3Oct 24Mar 25Aug 25Jan 26Jun 26Oct 26

Key statistics

Market cap
1.33B
Enterprise value
1.66B
Trailing P/E
0.00
Forward P/E
120.22
PEG ratio
0.00
Price / sales
1.28
Price / book
10.19
EPS (TTM)
-0.91
Beta
1.66
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-6.08%
Revenue (TTM)
1.04B
Revenue growth
5.80%
Free cash flow
-43.95M
Total cash
456.00M
Total debt
739.25M
Return on equity
-48.03%
Shares outstanding
69.58M
Short % of float
29.04%
50-day average
18.09
200-day average
18.94

Analyst view

Consensus: buy

Buy
Price target (mean) 27.76 +45.3% upside
Target (low)
18.00
Target (mean)
27.76
Target (high)
50.00
Ratings (0m) 25 13 buy · 12 hold · 0 sell
  • Strong buy2
  • Buy11
  • Hold12
  • Sell0
  • Strong sell0

Next earnings

Nov 5, 2026

Expected Nov 5, 2026. Consensus EPS estimate -0.2402.

Earnings history

Financials — quick view

All financials
TNDM Revenue — quarterly 254.56M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
TNDM Net income — quarterly -21.17M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
TNDM EPS — quarterly -0.31
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

TNDM recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2026Sep 30, 2026-0.24533———
Aug 6, 2026Jun 30, 2026-0.32074-0.31+0.01+3.35%
May 7, 2026Mar 31, 2026-0.46-0.30+0.16+34.78%
Feb 19, 2026Dec 31, 2025-0.05-0.01+0.04+80.00%
Nov 6, 2025Sep 30, 2025-0.31-0.310.000.00%
Aug 6, 2025Jun 30, 2025-0.40-0.48-0.08-20.00%

Upgrades / downgrades

TNDM analyst upgrades and downgrades
DateFirmActionFromTo
Oct 7, 2026Barclaysinit—Equal-Weight
Sep 30, 2026CitigroupmainNeutralNeutral
Sep 24, 2026Truist SecuritiesmainBuyBuy
Aug 21, 2026William Blairinit—Outperform
Aug 7, 2026CitigroupmainNeutralNeutral
Aug 7, 2026RBC CapitalmainOutperformOutperform

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on TNDM — it syncs with the Stock Master app.

Insider holders

TNDM insider holders
InsiderRelationLatest transactionDateShares held
ALLEN DICK PRetiredConversion of Exercise of derivative securityMay 20, 202650,903
BLICKENSTAFF KIM DDirectorSaleNov 20, 20240
CARPENTER RICKChief Technology OfficerConversion of Exercise of derivative securityAug 13, 202632,148
GASSER ELIZABETH ANNEOfficerConversion of Exercise of derivative securityAug 13, 202634,505
HANSEN SHANNON MARIEOfficerConversion of Exercise of derivative securityAug 13, 202633,585
MORRISON SUSAN MOfficerConversion of Exercise of derivative securityAug 13, 202652,788

Institution ownership

TNDM institution ownership
Holder% heldSharesValueReported
Blackrock Inc.16.65%11,583,125221.35MJun 29, 2026
Sessa Capital IM, L.P.7.33%5,100,00097.46MJun 29, 2026
Vanguard Portfolio Management LLC6.18%4,299,66782.17MJun 29, 2026
First Light Asset Management, LLC4.86%3,383,55364.66MJun 29, 2026
Vanguard Capital Management LLC4.45%3,096,53659.17MJun 29, 2026
State Street Corporation4.10%2,851,64654.49MJun 29, 2026

Fund ownership

TNDM fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.95%4,140,27879.12MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.14%2,186,91841.79MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.59%1,803,94734.47MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.26%1,570,01930.00MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund1.30%901,46717.23MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.13%788,50915.07MJun 29, 2026
Advertisement